Next-Generation Toxicology in Pharma & Biotech is a premier international training course taking place on 21–22 October 2026 in Basel, Switzerland, with the added flexibility of online live-stream participation. Designed for professionals in pharmaceutical, biotechnology, biologics, drug safety, toxicology, regulatory affairs, pharmacology, and preclinical development, this course provides a comprehensive overview of modern toxicology and its evolving role in drug development.
Led by distinguished industry experts Dr. Pelin Candarlioglu, Founder and Director of 3D and 3Rs Ltd, and Richard Knight, PhD, ERT, Co-founder of ApconiX and a highly experienced drug safety specialist, the program combines scientific expertise with practical industry applications. Participants will gain valuable insights into regulatory toxicology, investigative toxicology, New Approach Methodologies (NAMs), Microphysiological Systems (MPS), integrated testing strategies (IATA), AI and machine learning in toxicology, data quality, reproducibility, and human-relevant safety assessment models.